Transcriptional regulators of human oncoviruses: structural and functional implications for anticancer therapy

Ivona Nečasová1,2, Martin Stojaspal1,2, Edita Motyčáková1,2

  • 1Institute of Biophysics of the Czech Academy of Sciences, Scientific Incubator, Královopolská 135, Brno 612 65, Czech Republic.

NAR Cancer
|March 7, 2022
PubMed

Insights

Viral transcriptional regulators (vTRs) are key to viral infections and oncogenesis. Targeting these unique viral proteins offers a promising strategy for developing novel antiviral and anticancer therapies.

Area of Science:

  • Virology
  • Molecular Biology
  • Oncology

Background:

  • Viral transcriptional regulators (vTRs) are essential viral proteins that drive viral gene expression and replication.
  • vTRs interact with host proteins to evade immune detection, making them critical in viral pathogenesis and oncogenesis.
  • vTRs are distinct from host proteins, presenting them as attractive therapeutic targets.

Purpose of the Study:

  • To review the transcription strategies of vTRs from three human oncoviruses: hepatitis B virus (HBx), human T-lymphotropic virus type 1 (HBZ), and Epstein-Barr virus (Rta).
  • To critically examine the potential of vTRs as therapeutic targets for antiviral and anticancer strategies.
  • To discuss the implications of vTR regulation in oncogenesis and future therapeutic perspectives.

Main Methods:

  • Literature review of available structural and functional data on vTRs from HBx, HBZ, and Rta.
  • Analysis of viral genome transcription strategies employed by these vTRs.
  • Examination of vTRs' structure, binding partners, and their roles in transcription regulation.

Main Results:

  • Detailed description of the distinct transcription strategies of HBx, HBZ, and Rta.
  • Identification of key host binding partners crucial for vTR-mediated transcription regulation.
  • Evaluation of the advantages and challenges associated with targeting these vTRs in therapeutic contexts.

Conclusions:

  • vTRs employ sophisticated strategies to manipulate host transcription machinery, facilitating viral replication and oncogenesis.
  • Targeting vTRs presents a viable approach for developing novel antiviral and anticancer therapies due to their unique viral nature.
  • Further research into vTR structure-function relationships can unlock new avenues for therapeutic intervention against viral-associated cancers.

Related Concept Videos

Mechanisms of Retrovirus-induced Cancers01:51

Mechanisms of Retrovirus-induced Cancers

Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
5.4K
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
5.5K
Eukaryotic Transcription Inhibitors01:52

Eukaryotic Transcription Inhibitors

Certain biochemical processes, such as embryonic development and cell growth regulation, depend on the repression of specific genes. DNA binding proteins known as eukaryotic transcription inhibitors regulate the repression of gene expression in eukaryotes. The presence of these inhibitors at the required location and time in the cell is triggered by the presence of hormones and additional signals from other cells.
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
10.1K
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
5.2K
Covalently Linked Protein Regulators02:04

Covalently Linked Protein Regulators

Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein....
7.6K
Leaky Scanning02:28

Leaky Scanning

During most eukaryotic translation processes, the small 40S ribosome subunit scans an mRNA from its 5' end until it encounters the first start AUG codon. The large 60S ribosomal subunit then joins the smaller one to initiate protein synthesis. The location of the translation initiation is largely determined by the nucleotides near the start codon as there may be multiple translation initiation sites present on the mRNA.  Marilyn Kozak discovered that the sequence RCCAUGG (where R...
5.3K